Lal, Deepika <br/><br/>
Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models.  [electronic resource] 

 -  Molecular cancer therapeutics  Oct 2010 
 - 2737-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-10-0334  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracyclines--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Female<br/>Humans<br/>Karyotyping<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Receptors, Vascular Endothelial Growth Factor--genetics<br/>Recombinant Fusion Proteins--pharmacology<br/>Transplantation, Heterologous